Approval · Notice of Compliance 36026 · 2025
STOBOCLO: Notice of Compliance 36026
Issued September 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36026
- Date
- September 17, 2025
- Company
- Celltrion Inc.Incheon, Korea, Republic Of
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- PROLIA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STOBOCLO | 02560917 | Marketed |
Medicinal ingredients
- DENOSUMAB 60 MG per ML